Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins…
Continue Reading
What You Should Know: Today, Rev1 Ventures, the venture studio that helps entrepreneurs and corporations accelerate innovation, Nationwide Children’s Hospital, and The Ohio State University announce expanded support for life sciences companies with the launch of Rev1 Catalyst…
Continue Reading
Robotic-assisted knee replacement surgery with laser technology is garnering attention as a groundbreaking advancement in orthopaedic care. With its array of benefits for patients and surgeons alike, this cutting-edge approach is transforming the landscape…
Continue Reading
CAR T-cell therapy is used to treat patients with blood cancers such as multiple myeloma. Since it can cause serious side effects, patients are usually hospitalized and monitored for up to two weeks after…
Continue Reading
Researchers at the Harvard Wyss Institute have developed an anti-cancer biomaterial treatment that combines adoptive T cell therapy and cancer vaccine technology to treat solid tumors. The researchers have called their technique SIVET, which…
Continue Reading
Researchers at the Harvard Wyss Institute have developed a new type of cell therapy for multiple sclerosis patients. The technique involves taking a blood sample from the patient being treated, isolating a sample of…
Continue Reading
Adaptimmune and TCR2 Therapeutics, two clinical-stage biotechs that have recently cut staff to conserve capital, are coming together in a deal that aligns their cell therapy strategies. The business combination also extends the new…
Continue Reading
Chroma Medicine, a biotech company developing therapies that turn genes on or off as a way of treating genetic disorders, has raised $135 million as it works to generate data that could show the…
Continue Reading
Patients whose blood cancer advances after initial treatments have one last therapeutic option: the engineering of their immune cells into a living medicine. But cancer is crafty and it often finds a way to…
Continue Reading
There are so many challenges that we are currently facing in the world of healthcare, that possibly adding another one is overwhelming to think about. AI automation is still so new that it’s hard…
Continue Reading
